Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. Calendar
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
Delayed Nyse  -  04:00 2022-12-06 pm EST
48.70 USD   -0.98%
11/29Transcript : Qiagen N.V. Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 09:15 AM
CI
11/21QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
BU
11/21Qiagen N.V. Launches Monkeypox Test for NeuMoDx Platform to Fight Global Outbreak by Boosting Research and Surveillance
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart QIAGEN N.V.
Upcoming events on QIAGEN N.V.
02/07/23 FY 2022 Earnings Release (Projected)
05/02/23 Q1 2023 Earnings Release (Projected)
07/27/23 Interim 2023 Earnings Release (Projected)
11/01/23 Q3 2023 Earnings Release (Projected)
Past events on QIAGEN N.V.
11/08/22 | 09:00am Q3 2022 Earnings Call
11/07/22 | 04:05pm Q3 2022 Earnings Release
09/06/22 Commerzbank Corporate Conference
07/28/22 | 09:30am Interim 2022 Earnings Call
07/27/22 | 04:05pm Interim 2022 Earnings Release
06/23/22 | 04:00am Annual General Meeting
06/14/22 | 03:00am Exane BNPP CEO Conference
06/08/22 | 10:30am Jefferies Healthcare Conference
05/25/22 | 02:30am SGCIB Conference
05/24/22 | 03:00am Deutsche Bank dbAccess German Corporate Conference
Past dividends on QIAGEN N.V.
01/25/17 1.04 usd
Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
1 418
1 416
0,11%
1 502
1 514
-0,82%
1 526
1 526
0,06%
1 870
1 858
0,68%
2 252
2 198
2,4%
 
2 135
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
476
477
-0,16%
514
527
-2,5%
552
532
3,7%
748
723
3,4%
884
870
1,7%
 
810
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
372
361
2,8%
403
407
-0,98%
422
412
2,5%
627
623
0,57%
755
714
5,7%
 
653
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
114
158
-28%
226
233
-2,9%
-77,8
-77,9
0,13%
439
364
21%
626
564
11%
 
538
 
Net income
M $
Released
Forecast
Spread
40,4
29,9
35%
190
190
0,20%
-41,5
-29,5
-41%
359
294
22%
513
475
7,8%
 
430
 
EPS
$
Released
Forecast
Spread
0,17
0,13
36%
0,82
0,79
3,8%
-0,18
-0,11
-63%
1,53
1,27
21%
2,21
2,11
4,8%
 
1,84
 
Announcement Date01/31/201802/04/201902/04/202002/09/202102/08/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
535
499
7,3%
582
533
9,2%
628
591
6,4%
516
500
3,2%
500
482
3,7%
 
486
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
197
183
7,9%
232
207
12%
266
240
11%
179
165
8,1%
176
158
11%
 
166
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
165
155
5,9%
199
171
16%
232
205
13%
146
133
10%
144
129
11%
 
129
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
151
109
39%


 


 


 
95,7
94,5
1,3%
 

 
Net income
M $
Released
Forecast
Spread
133
96,1
39%
129
115
13%
155
138
12%
96,7
78,2
24%
82,4
78,1
5,4%
 
79,6
 
EPS
Released
Forecast
Spread
0,57
0,42
37%
0,56
0,50
12%
0,67
0,60
12%
0,42
0,35
21%
0,36
0,34
6,4%
 
0,34
 
Announcement Date11/03/202102/08/202204/27/202207/26/202211/07/2022-
Previous year Next Year
Upcoming sector events for QIAGEN N.V.
More events
Past sector events for QIAGEN N.V.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise